Absci Corp (ABSI NASDAQ) stock market data APIs
$3.478
0.03(0.9%)
as of December 29, 2025
Try our APIs with
free plan!
Absci Corp Financial Data Overview
Price chart is built with
Anychart
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Prev. Close
3.478
Open
3.5081
High
3.5453
Low
3.4094
52 wk Range
2.01-6.33
Market Cap
519 M
Shares Outstanding
150 M
Revenue
2 815 K
EPS
-0.2
Beta
2.14
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Absci Corp (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Absci Corp data using free add-ons & libraries
Get Absci Corp Fundamental Data
Absci Corp Fundamental data includes:
- Net Revenue: 2 815 K
- EBITDA: -105 502 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-12
- EPS/Forecast: -0.2
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Absci Corp News
New
Absci Corporation (ABSI) Draws Full Buy Consensus With 150% Upside Potential
Absci Corporation (NASDAQ:ABSI) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, Absci Corporation (NASDAQ:ABSI) is a consensus buy among all nine analysts covering the stoc...
Absci Corporation (NASDAQ:ABSI)’s ABS‑201 Shows Promise in Hair Loss Treatment, Analysts See Upside
Absci Corporation (NASDAQ:ABSI) is one of the best multibagger penny stocks to buy right now. On December 12, Needham’s Gil Blum reiterated a Buy rating on Absci Corporation (NASDAQ:ABSI) with a $7 ...
After-Hours Rally: Stoke Therapeutics, Alpha Tau Medical, Compass Pathways Lead Biotech Movers
(RTTNews) - Biotech stocks showed sharp moves in extended trading, with several names rebounding after steep regular-session losses. Fresh clinical data, FDA designations, and financing announcements ...
ABSI Stock Up on Initiating Dosing in Androgenetic Alopecia Study
Shares of Absci Corporation ABSI jumped 13.4% on Thursday after the company initiated dosing in an early-to-mid-stage study evaluating its investigational candidate, ABS-201, for androgenetic alopecia...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
